chrX-111682233-C-T

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2

The NM_001257231.2(ALG13):​c.8C>T​(p.Thr3Ile) variant causes a missense, splice region change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0141 in 1,197,624 control chromosomes in the GnomAD database, including 139 homozygotes. There are 5,188 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. 8/11 in silico tools predict a benign outcome for this variant. 1/1 splice prediction tools predict no significant impact on normal splicing. Variant has been reported in ClinVar as Benign (★★). Synonymous variant affecting the same amino acid position (i.e. T3T) has been classified as Uncertain significance.

Frequency

Genomes: 𝑓 0.0092 ( 12 hom., 281 hem., cov: 23)
Exomes 𝑓: 0.015 ( 127 hom. 4907 hem. )

Consequence

ALG13
NM_001257231.2 missense, splice_region

Scores

1
1
6

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:6

Conservation

PhyloP100: 0.657

Publications

5 publications found
Variant links:
Genes affected
ALG13 (HGNC:30881): (ALG13 UDP-N-acetylglucosaminyltransferase subunit) The protein encoded by this gene is a subunit of a bipartite UDP-N-acetylglucosamine transferase. It heterodimerizes with asparagine-linked glycosylation 14 homolog to form a functional UDP-GlcNAc glycosyltransferase that catalyzes the second sugar addition of the highly conserved oligosaccharide precursor in endoplasmic reticulum N-linked glycosylation. Multiple transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Dec 2009]
ALG13 Gene-Disease associations (from GenCC):
  • genetic developmental and epileptic encephalopathy
    Inheritance: XL Classification: DEFINITIVE Submitted by: ClinGen
  • developmental and epileptic encephalopathy, 36
    Inheritance: XL Classification: STRONG, SUPPORTIVE, LIMITED Submitted by: Orphanet, Labcorp Genetics (formerly Invitae), Ambry Genetics, G2P
  • non-syndromic X-linked intellectual disability
    Inheritance: XL Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.0039321184).
BP6
Variant X-111682233-C-T is Benign according to our data. Variant chrX-111682233-C-T is described in ClinVar as Benign. ClinVar VariationId is 238290.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population nfe. GnomAd4 allele frequency = 0.00923 (1035/112115) while in subpopulation NFE AF = 0.0165 (877/53223). AF 95% confidence interval is 0.0156. There are 12 homozygotes in GnomAd4. There are 281 alleles in the male GnomAd4 subpopulation. Median coverage is 23. This position passed quality control check.
BS2
High Homozygotes in GnomAd4 at 12 XL gene

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_001257231.2. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
ALG13
NM_001099922.3
MANE Select
c.183C>Tp.Tyr61Tyr
synonymous
Exon 2 of 27NP_001093392.1Q9NP73-1
ALG13
NM_001257231.2
c.8C>Tp.Thr3Ile
missense splice_region
Exon 2 of 27NP_001244160.1Q9NP73-3
ALG13
NM_001257241.3
c.8C>Tp.Thr3Ile
missense splice_region
Exon 2 of 4NP_001244170.1

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
ALG13
ENST00000394780.8
TSL:2 MANE Select
c.183C>Tp.Tyr61Tyr
synonymous
Exon 2 of 27ENSP00000378260.3Q9NP73-1
ALG13
ENST00000371979.7
TSL:1
c.183C>Tp.Tyr61Tyr
synonymous
Exon 2 of 4ENSP00000361047.3Q9NP73-2
ALG13
ENST00000927365.1
c.183C>Tp.Tyr61Tyr
synonymous
Exon 2 of 27ENSP00000597424.1

Frequencies

GnomAD3 genomes
AF:
0.00925
AC:
1036
AN:
112060
Hom.:
12
Cov.:
23
show subpopulations
Gnomad AFR
AF:
0.00224
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00198
Gnomad ASJ
AF:
0.00264
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00114
Gnomad FIN
AF:
0.00850
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0165
Gnomad OTH
AF:
0.00397
GnomAD2 exomes
AF:
0.00809
AC:
1393
AN:
172113
AF XY:
0.00763
show subpopulations
Gnomad AFR exome
AF:
0.00207
Gnomad AMR exome
AF:
0.00305
Gnomad ASJ exome
AF:
0.000990
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00824
Gnomad NFE exome
AF:
0.0142
Gnomad OTH exome
AF:
0.00555
GnomAD4 exome
AF:
0.0146
AC:
15858
AN:
1085509
Hom.:
127
Cov.:
29
AF XY:
0.0139
AC XY:
4907
AN XY:
352453
show subpopulations
African (AFR)
AF:
0.00196
AC:
51
AN:
26031
American (AMR)
AF:
0.00311
AC:
106
AN:
34113
Ashkenazi Jewish (ASJ)
AF:
0.00199
AC:
38
AN:
19057
East Asian (EAS)
AF:
0.00
AC:
0
AN:
29699
South Asian (SAS)
AF:
0.00129
AC:
67
AN:
51758
European-Finnish (FIN)
AF:
0.00892
AC:
359
AN:
40267
Middle Eastern (MID)
AF:
0.000490
AC:
2
AN:
4078
European-Non Finnish (NFE)
AF:
0.0176
AC:
14677
AN:
834956
Other (OTH)
AF:
0.0123
AC:
558
AN:
45550
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.465
Heterozygous variant carriers
0
495
990
1485
1980
2475
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
562
1124
1686
2248
2810
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00923
AC:
1035
AN:
112115
Hom.:
12
Cov.:
23
AF XY:
0.00819
AC XY:
281
AN XY:
34293
show subpopulations
African (AFR)
AF:
0.00223
AC:
69
AN:
30873
American (AMR)
AF:
0.00198
AC:
21
AN:
10618
Ashkenazi Jewish (ASJ)
AF:
0.00264
AC:
7
AN:
2650
East Asian (EAS)
AF:
0.00
AC:
0
AN:
3565
South Asian (SAS)
AF:
0.00114
AC:
3
AN:
2635
European-Finnish (FIN)
AF:
0.00850
AC:
52
AN:
6120
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
218
European-Non Finnish (NFE)
AF:
0.0165
AC:
877
AN:
53223
Other (OTH)
AF:
0.00392
AC:
6
AN:
1530
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.505
Heterozygous variant carriers
0
41
82
124
165
206
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
20
40
60
80
100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00719
Hom.:
91
Bravo
AF:
0.00844
TwinsUK
AF:
0.0208
AC:
77
ALSPAC
AF:
0.0145
AC:
42
ESP6500AA
AF:
0.00104
AC:
4
ESP6500EA
AF:
0.0162
AC:
109
ExAC
AF:
0.00893
AC:
1084

ClinVar

ClinVar submissions
Significance:Benign
Revision:criteria provided, multiple submitters, no conflicts
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
-
2
Developmental and epileptic encephalopathy, 36 (2)
-
-
2
not provided (2)
-
-
1
Inborn genetic diseases (1)
-
-
1
not specified (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Uncertain
0.42
BayesDel_addAF
Benign
-0.57
T
BayesDel_noAF
Benign
-0.57
CADD
Benign
13
DANN
Benign
0.52
FATHMM_MKL
Benign
0.71
D
LIST_S2
Benign
0.24
T
MetaRNN
Benign
0.0039
T
PhyloP100
0.66
Sift4G
Pathogenic
0.0010
D
Polyphen
0.082
B
Vest4
0.049
MVP
0.49
GERP RS
4.3
PromoterAI
-0.015
Neutral
Mutation Taster
=288/12
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs146925326; hg19: chrX-110925461; COSMIC: COSV106087355; API